Δ7-Avenasterol | CAS 23290-26-8 - Request Quote
Δ7-Avenasterol
| SZ CAT No: | SZ-S100007 |
| CAS No | 23290-26-8 |
| Mol.F. | C29H48O |
| Mol.Wt. | 412.7 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Synonym :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Δ7-Avenasterol is chemically (3S,5S,9R,10S,13R,14R,17R)-17-((R,Z)-5-Isopropylhept-5-en-2-yl)-10,13-dimethyl-2,3,4,5,6,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol. It is also known as Avenasterol ; 24Z-Ethylidenelathosterol. Δ7-Avenasterol is supplied with detailed characterization data compliant with regulatory guideline. Δ7-Avenasterol can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Stigmastanol.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 23290-26-8
Purchase 23290-26-8
Order 23290-26-8
Enquire 23290-26-8
price of 23290-26-8
23290-26-8 Supplier
23290-26-8 Manufacturer
23290-26-8 Exporter
buy high quality Δ7-Avenasterol
Purchase Δ7-Avenasterol
Δ7-Avenasterol suppliers
Δ7-Avenasterol manufacturers
Δ7-Avenasterol price
Order Δ7-Avenasterol
Enquire Δ7-Avenasterol
Δ7-Avenasterol cost
Δ7-Avenasterol Supplier
Δ7-Avenasterol Distributor
Δ7-Avenasterol for Method Validation
Stigmastanol Reference Standard
Δ7-Avenasterol for ANDA Filing
Δ7-Avenasterol for Forced Degradation Studies
Δ7-Avenasterol Identification Standards
Δ7-Avenasterol for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.